Stephen Sheldon

Stephen Sheldon discloses dealings in PaxMedica, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 19 November 2022 to 12 March 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 14 March 2024: a share grant of €2,118, in PaxMedica, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.